English
Insider transactions
EDGARPROTAGONIST THERAPEUTICS, INC.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.
A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.
Window: transactions dated on or after 2025-11-21.
- Open-market purchases (code P)
- 0 transactions, — shares
- Open-market sales (code S)
- 37 transactions, 850,859 shares
- Sum of shares × price per share: 95,330,050.34
Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.
Showing 1–50 of 127
| Date | Reporting owner | Code | Acquired or disposed | Shares | Price per share, as filed | Value (derived) | Shares owned after | Direct or indirect | Rule 10b5-1 box | Notes | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-19 Filed 2026-11-20 | PATEL DINESH V PH D Director · Officer: President and CEO | GBona fide gift | Disposed (D) | 300 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 522,668 | Direct (D) | No | F1
| Open filing 0001104659-26-130668 Read from the filing’s XML Dispute this row |
| 2026-11-16 Filed 2026-11-17 | MOLINA ARTURO MD Officer: Chief Medical Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 2,718 | 124.65 | 338,798.7Derived: shares × price per share. Exact value 338798.70. | 81,397 | Direct (D) | No | F1
| Open filing 0001104659-26-129244 Read from the filing’s XML Dispute this row |
| 2026-09-30 Filed 2026-10-02 | Ali Asif Officer: Chief Financial Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 9,229 | 38.98 | 359,746.42Derived: shares × price per share. Exact value 359746.42. | 68,232 | Direct (D) | Yes | F1
| Open filing 0001104659-26-113279 Read from the filing’s XML Dispute this row |
| 2026-09-30 Filed 2026-10-02 | Ali Asif Officer: Chief Financial Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 28,438 | 23.42 | 666,017.96Derived: shares × price per share. Exact value 666017.96. | 96,670 | Direct (D) | Yes | F1
| Open filing 0001104659-26-113279 Read from the filing’s XML Dispute this row |
| 2026-09-30 Filed 2026-10-02 | Ali Asif Officer: Chief Financial Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 15,650 | 19.19 | 300,323.5Derived: shares × price per share. Exact value 300323.50. | 112,320 | Direct (D) | Yes | F1
| Open filing 0001104659-26-113279 Read from the filing’s XML Dispute this row |
| 2026-09-30 Filed 2026-10-02 | Ali Asif Officer: Chief Financial Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 5,312 | 12.17 | 64,647.04Derived: shares × price per share. Exact value 64647.04. | 117,632 | Direct (D) | Yes | F1
| Open filing 0001104659-26-113279 Read from the filing’s XML Dispute this row |
| 2026-09-30 Filed 2026-10-02 | Ali Asif Officer: Chief Financial Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 12,595 | 141.77 | 1,785,593.15Derived: shares × price per share. Exact value 1785593.15. | 105,037 | Direct (D) | Yes | F1, F2
| Open filing 0001104659-26-113279 Read from the filing’s XML Dispute this row |
| 2026-09-30 Filed 2026-10-02 | Ali Asif Officer: Chief Financial Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 46,034 | 141.78 | 6,526,700.52Derived: shares × price per share. Exact value 6526700.52. | 59,003 | Direct (D) | Yes | F1, F3
| Open filing 0001104659-26-113279 Read from the filing’s XML Dispute this row |
| 2026-09-30 Filed 2026-10-02 | Ali Asif Officer: Chief Financial Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 9,229 | 0 | — | 29,291 | Direct (D) | Yes | F4
| Open filing 0001104659-26-113279 Read from the filing’s XML Dispute this row |
| 2026-09-30 Filed 2026-10-02 | Ali Asif Officer: Chief Financial Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 28,438 | 0 | — | 49,562 | Direct (D) | Yes | F5
| Open filing 0001104659-26-113279 Read from the filing’s XML Dispute this row |
| 2026-09-30 Filed 2026-10-02 | Ali Asif Officer: Chief Financial Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 15,650 | 0 | — | 51,150 | Direct (D) | Yes | F6
| Open filing 0001104659-26-113279 Read from the filing’s XML Dispute this row |
| 2026-09-30 Filed 2026-10-02 | Ali Asif Officer: Chief Financial Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 5,312 | 0 | — | 25,235 | Direct (D) | Yes | F7
| Open filing 0001104659-26-113279 Read from the filing’s XML Dispute this row |
| 2026-09-10 Filed 2026-09-10 | PATEL DINESH V PH D Director · Officer: President and CEO | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 7,278 | 21.58 | 157,059.24Derived: shares × price per share. Exact value 157059.24. | 530,246 | Direct (D) | Yes | F1
| Open filing 0001104659-26-106831 Read from the filing’s XML Dispute this row |
| 2026-09-10 Filed 2026-09-10 | PATEL DINESH V PH D Director · Officer: President and CEO | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 7,278 | 144.10 | 1,048,759.8Derived: shares × price per share. Exact value 1048759.80. | 522,968 | Direct (D) | Yes | F4
| Open filing 0001104659-26-106831 Read from the filing’s XML Dispute this row |
| 2026-09-10 Filed 2026-09-10 | PATEL DINESH V PH D Director · Officer: President and CEO | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 7,278 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 0 | Direct (D) | Yes | F1
| Open filing 0001104659-26-106831 Read from the filing’s XML Dispute this row |
| 2026-09-09 Filed 2026-09-10 | PATEL DINESH V PH D Director · Officer: President and CEO | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 63,548 | 21.58 | 1,371,365.84Derived: shares × price per share. Exact value 1371365.84. | 586,516 | Direct (D) | Yes | F1
| Open filing 0001104659-26-106831 Read from the filing’s XML Dispute this row |
| 2026-09-09 Filed 2026-09-10 | PATEL DINESH V PH D Director · Officer: President and CEO | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 63,548 | 146.18 | 9,289,446.64Derived: shares × price per share. Exact value 9289446.64. | 522,968 | Direct (D) | Yes | F3
| Open filing 0001104659-26-106831 Read from the filing’s XML Dispute this row |
| 2026-09-09 Filed 2026-09-10 | PATEL DINESH V PH D Director · Officer: President and CEO | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 63,548 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 7,278 | Direct (D) | Yes | F1
| Open filing 0001104659-26-106831 Read from the filing’s XML Dispute this row |
| 2026-09-08 Filed 2026-09-10 | PATEL DINESH V PH D Director · Officer: President and CEO | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 54,174 | 21.58 | 1,169,074.92Derived: shares × price per share. Exact value 1169074.92. | 577,142 | Direct (D) | Yes | F1
| Open filing 0001104659-26-106831 Read from the filing’s XML Dispute this row |
| 2026-09-08 Filed 2026-09-10 | PATEL DINESH V PH D Director · Officer: President and CEO | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 54,174 | 145.87 | 7,902,361.38Derived: shares × price per share. Exact value 7902361.38. | 522,968 | Direct (D) | Yes | F2
| Open filing 0001104659-26-106831 Read from the filing’s XML Dispute this row |
| 2026-09-08 Filed 2026-09-10 | PATEL DINESH V PH D Director · Officer: President and CEO | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 54,174 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 70,826 | Direct (D) | Yes | F1
| Open filing 0001104659-26-106831 Read from the filing’s XML Dispute this row |
| 2026-09-03 Filed 2026-09-08 | PATEL DINESH V PH D Director · Officer: President and CEO | GBona fide gift | Disposed (D) | 510 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 522,968 | Direct (D) | No | F1
| Open filing 0001104659-26-105955 Read from the filing’s XML Dispute this row |
| 2026-08-11 Filed 2026-08-12 | PATEL DINESH V PH D Director · Officer: President and CEO | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 34,239 | 21.58 | 738,877.62Derived: shares × price per share. Exact value 738877.62. | 557,717 | Direct (D) | Yes | F1
| Open filing 0001104659-26-095111 Read from the filing’s XML Dispute this row |
| 2026-08-11 Filed 2026-08-12 | PATEL DINESH V PH D Director · Officer: President and CEO | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 34,239 | 148.52 | 5,085,176.28Derived: shares × price per share. Exact value 5085176.28. | 523,478 | Direct (D) | Yes | F3
| Open filing 0001104659-26-095111 Read from the filing’s XML Dispute this row |
| 2026-08-11 Filed 2026-08-12 | PATEL DINESH V PH D Director · Officer: President and CEO | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 34,239 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 125,000 | Direct (D) | Yes | F1
| Open filing 0001104659-26-095111 Read from the filing’s XML Dispute this row |
| 2026-08-10 Filed 2026-08-12 | PATEL DINESH V PH D Director · Officer: President and CEO | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 65,761 | 21.58 | 1,419,122.38Derived: shares × price per share. Exact value 1419122.38. | 589,239 | Direct (D) | Yes | F1
| Open filing 0001104659-26-095111 Read from the filing’s XML Dispute this row |
| 2026-08-10 Filed 2026-08-12 | PATEL DINESH V PH D Director · Officer: President and CEO | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 65,761 | 149.11 | 9,805,622.71Derived: shares × price per share. Exact value 9805622.71. | 523,478 | Direct (D) | Yes | F2
| Open filing 0001104659-26-095111 Read from the filing’s XML Dispute this row |
| 2026-08-10 Filed 2026-08-12 | PATEL DINESH V PH D Director · Officer: President and CEO | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 65,761 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 159,239 | Direct (D) | Yes | F1
| Open filing 0001104659-26-095111 Read from the filing’s XML Dispute this row |
| 2026-06-23 Filed 2026-06-25 | Waddill William D. Director | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 9,000 | 16.54 | 148,860Derived: shares × price per share. Exact value 148860.00. | 16,825 | Direct (D) | Yes | F1
| Open filing 0001104659-26-077761 Read from the filing’s XML Dispute this row |
| 2026-06-23 Filed 2026-06-25 | Waddill William D. Director | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 9,000 | 117.94 | 1,061,460Derived: shares × price per share. Exact value 1061460.00. | 7,825 | Direct (D) | Yes | F2
| Open filing 0001104659-26-077761 Read from the filing’s XML Dispute this row |
| 2026-06-23 Filed 2026-06-25 | Waddill William D. Director | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 9,000 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 0 | Direct (D) | Yes | F3
| Open filing 0001104659-26-077761 Read from the filing’s XML Dispute this row |
| 2026-06-10 Filed 2026-06-11 | Waddill William D. Director | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 3,000 | 11.8 | 35,400Derived: shares × price per share. Exact value 35400.0. | 10,825 | Direct (D) | Yes | F1
| Open filing 0001104659-26-073049 Read from the filing’s XML Dispute this row |
| 2026-06-10 Filed 2026-06-11 | Waddill William D. Director | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 6,000 | 16.54 | 99,240Derived: shares × price per share. Exact value 99240.00. | 16,825 | Direct (D) | Yes | F1
| Open filing 0001104659-26-073049 Read from the filing’s XML Dispute this row |
| 2026-06-10 Filed 2026-06-11 | Waddill William D. Director | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 9,000 | 107.68 | 969,120Derived: shares × price per share. Exact value 969120.00. | 7,825 | Direct (D) | Yes | F2
| Open filing 0001104659-26-073049 Read from the filing’s XML Dispute this row |
| 2026-06-10 Filed 2026-06-11 | Waddill William D. Director | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 3,000 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 0 | Direct (D) | Yes | F3
| Open filing 0001104659-26-073049 Read from the filing’s XML Dispute this row |
| 2026-06-10 Filed 2026-06-11 | Waddill William D. Director | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 6,000 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 9,000 | Direct (D) | Yes | F3
| Open filing 0001104659-26-073049 Read from the filing’s XML Dispute this row |
| 2026-05-29 Filed 2026-06-01 | Waddill William D. Director | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 9,000 | 11.8 | 106,200Derived: shares × price per share. Exact value 106200.0. | 16,825 | Direct (D) | Yes | F1
| Open filing 0001104659-26-069047 Read from the filing’s XML Dispute this row |
| 2026-05-29 Filed 2026-06-01 | Waddill William D. Director | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 9,000 | 99.64 | 896,760Derived: shares × price per share. Exact value 896760.00. | 7,825 | Direct (D) | Yes | — | Open filing 0001104659-26-069047 Read from the filing’s XML Dispute this row |
| 2026-05-29 Filed 2026-06-01 | Waddill William D. Director | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 9,000 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 3,000 | Direct (D) | Yes | F2
| Open filing 0001104659-26-069047 Read from the filing’s XML Dispute this row |
| 2026-05-12 Filed 2026-05-14 | PATEL DINESH V PH D Director · Officer: President and CEO | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 75,000 | 21.58 | 1,618,500Derived: shares × price per share. Exact value 1618500.00. | 598,478 | Direct (D) | Yes | F1
| Open filing 0001104659-26-061476 Read from the filing’s XML Dispute this row |
| 2026-05-12 Filed 2026-05-14 | PATEL DINESH V PH D Director · Officer: President and CEO | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 75,000 | 100.12 | 7,509,000Derived: shares × price per share. Exact value 7509000.00. | 523,478 | Direct (D) | Yes | F2
| Open filing 0001104659-26-061476 Read from the filing’s XML Dispute this row |
| 2026-05-12 Filed 2026-05-14 | PATEL DINESH V PH D Director · Officer: President and CEO | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 75,000 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 225,000 | Direct (D) | Yes | F3
| Open filing 0001104659-26-061476 Read from the filing’s XML Dispute this row |
| 2026-05-12 Filed 2026-05-12 | PATEL DINESH V PH D Director · Officer: President and CEO | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 75,000 | 21.58 | 1,618,500Derived: shares × price per share. Exact value 1618500.00. | 598,478 | Direct (D) | No | — | Open filing 0001104659-26-059591 Read from the filing’s XML Dispute this row |
| 2026-05-12 Filed 2026-05-12 | PATEL DINESH V PH D Director · Officer: President and CEO | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 75,000 | 100.12 | 7,509,000Derived: shares × price per share. Exact value 7509000.00. | 523,478 | Direct (D) | No | F1
| Open filing 0001104659-26-059591 Read from the filing’s XML Dispute this row |
| 2026-05-12 Filed 2026-05-12 | PATEL DINESH V PH D Director · Officer: President and CEO | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 75,000 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 225,000 | Direct (D) | No | F2
| Open filing 0001104659-26-059591 Read from the filing’s XML Dispute this row |
| 2026-05-08 Filed 2026-05-11 | Giraudo Bryan Director | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 6,000 | 100.00 | 600,000Derived: shares × price per share. Exact value 600000.00. | 0 | Indirect (I) By Bryan Courtney Giraudo Trust | No | — | Open filing 0001104659-26-058860 Read from the filing’s XML Dispute this row |
| 2026-05-08 Filed 2026-05-11 | Giraudo Bryan Director | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 5,130 | 100.00 | 513,000Derived: shares × price per share. Exact value 513000.00. | 12,695 | Direct (D) | No | — | Open filing 0001104659-26-058860 Read from the filing’s XML Dispute this row |
| 2026-05-07 Filed 2026-05-11 | Giraudo Bryan Director | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 24,000 | 6.45 | 154,800Derived: shares × price per share. Exact value 154800.00. | 31,825 | Direct (D) | No | F1
| Open filing 0001104659-26-058860 Read from the filing’s XML Dispute this row |
| 2026-05-07 Filed 2026-05-11 | Giraudo Bryan Director | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 12,000 | 6.98 | 83,760Derived: shares × price per share. Exact value 83760.00. | 43,825 | Direct (D) | No | — | Open filing 0001104659-26-058860 Read from the filing’s XML Dispute this row |
| 2026-05-07 Filed 2026-05-11 | Giraudo Bryan Director | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 36,000 | 100.14 | 3,605,040Derived: shares × price per share. Exact value 3605040.00. | 27,825 | Direct (D) | No | F2
| Open filing 0001104659-26-058860 Read from the filing’s XML Dispute this row |
Institutional holders (Form 13F)
No Form 13F position in this issuer is placed in the store. A holder not yet linked or not yet filed is absent, not zero.
Trades by members of Congress
Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.
No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.
5% holders (Schedule 13D and 13G)
Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.
| Holder | Percent of class | Shares held | Event date | Form | Source |
|---|---|---|---|---|---|
| BlackRock, Inc. Common Stock | 15.2 | 9,834,146 | 09/30/2026 Filed 2026-10-27 | SCHEDULE 13G/AAmendment 8 | Open filing 0002012383-26-003834 Dispute this row |
| Farallon Capital Management, L.L.C. Common Stock, par value $0.00001 per share (the "Shares") | 9.99 | 6,433,119 | 06/30/2026 Filed 2026-08-13 | SCHEDULE 13G/AAmendment 9 | Open filing 0000908834-26-000405 Dispute this row |
| Farallon Capital Partners, L.P. Common Stock, par value $0.00001 per share (the "Shares") | 0 | 0 | 06/30/2026 Filed 2026-08-13 | SCHEDULE 13G/AAmendment 9 | Open filing 0000908834-26-000405 Dispute this row |
| Farallon Capital Institutional Partners, L.P. Common Stock, par value $0.00001 per share (the "Shares") | 0 | 0 | 06/30/2026 Filed 2026-08-13 | SCHEDULE 13G/AAmendment 9 | Open filing 0000908834-26-000405 Dispute this row |
| Farallon Capital Institutional Partners II, L.P. Common Stock, par value $0.00001 per share (the "Shares") | 0 | 0 | 06/30/2026 Filed 2026-08-13 | SCHEDULE 13G/AAmendment 9 | Open filing 0000908834-26-000405 Dispute this row |
| Farallon Capital Institutional Partners III, L.P. Common Stock, par value $0.00001 per share (the "Shares") | 0 | 0 | 06/30/2026 Filed 2026-08-13 | SCHEDULE 13G/AAmendment 9 | Open filing 0000908834-26-000405 Dispute this row |
| Four Crossings Institutional Partners V, L.P. Common Stock, par value $0.00001 per share (the "Shares") | 0 | 0 | 06/30/2026 Filed 2026-08-13 | SCHEDULE 13G/AAmendment 9 | Open filing 0000908834-26-000405 Dispute this row |
| Farallon Capital Offshore Investors II, L.P. Common Stock, par value $0.00001 per share (the "Shares") | 0 | 0 | 06/30/2026 Filed 2026-08-13 | SCHEDULE 13G/AAmendment 9 | Open filing 0000908834-26-000405 Dispute this row |
| Farallon Capital (AM) Investors, L.P. Common Stock, par value $0.00001 per share (the "Shares") | 0 | 0 | 06/30/2026 Filed 2026-08-13 | SCHEDULE 13G/AAmendment 9 | Open filing 0000908834-26-000405 Dispute this row |
| Farallon Capital F5 Master I, L.P. Common Stock, par value $0.00001 per share (the "Shares") | 0 | 0 | 06/30/2026 Filed 2026-08-13 | SCHEDULE 13G/AAmendment 9 | Open filing 0000908834-26-000405 Dispute this row |
| Farallon Healthcare Partners Master, L.P. Common Stock, par value $0.00001 per share (the "Shares") | 0 | 0 | 06/30/2026 Filed 2026-08-13 | SCHEDULE 13G/AAmendment 9 | Open filing 0000908834-26-000405 Dispute this row |
| Farallon Partners, L.L.C. Common Stock, par value $0.00001 per share (the "Shares") | 0 | 0 | 06/30/2026 Filed 2026-08-13 | SCHEDULE 13G/AAmendment 9 | Open filing 0000908834-26-000405 Dispute this row |
| Farallon Institutional (GP) V, L.L.C. Common Stock, par value $0.00001 per share (the "Shares") | 0 | 0 | 06/30/2026 Filed 2026-08-13 | SCHEDULE 13G/AAmendment 9 | Open filing 0000908834-26-000405 Dispute this row |
| Farallon F5 (GP), L.L.C. Common Stock, par value $0.00001 per share (the "Shares") | 0 | 0 | 06/30/2026 Filed 2026-08-13 | SCHEDULE 13G/AAmendment 9 | Open filing 0000908834-26-000405 Dispute this row |
| Farallon Healthcare Partners (GP), L.L.C. Common Stock, par value $0.00001 per share (the "Shares") | 0 | 0 | 06/30/2026 Filed 2026-08-13 | SCHEDULE 13G/AAmendment 9 | Open filing 0000908834-26-000405 Dispute this row |
| Dapice Joshua J. Common Stock, par value $0.00001 per share (the "Shares") | 9.99 | 6,433,119 | 06/30/2026 Filed 2026-08-13 | SCHEDULE 13G/AAmendment 9 | Open filing 0000908834-26-000405 Dispute this row |
| Dreyfuss, Philip D. Common Stock, par value $0.00001 per share (the "Shares") | 9.99 | 6,433,119 | 06/30/2026 Filed 2026-08-13 | SCHEDULE 13G/AAmendment 9 | Open filing 0000908834-26-000405 Dispute this row |
| Dunn Hannah E. Common Stock, par value $0.00001 per share (the "Shares") | 9.99 | 6,433,119 | 06/30/2026 Filed 2026-08-13 | SCHEDULE 13G/AAmendment 9 | Open filing 0000908834-26-000405 Dispute this row |
| Gehani, Varun N. Common Stock, par value $0.00001 per share (the "Shares") | 9.99 | 6,433,119 | 06/30/2026 Filed 2026-08-13 | SCHEDULE 13G/AAmendment 9 | Open filing 0000908834-26-000405 Dispute this row |
| Giauque, Nicolas Common Stock, par value $0.00001 per share (the "Shares") | 9.99 | 6,433,119 | 06/30/2026 Filed 2026-08-13 | SCHEDULE 13G/AAmendment 9 | Open filing 0000908834-26-000405 Dispute this row |
| Husen, Avner A. Common Stock, par value $0.00001 per share (the "Shares") | 9.99 | 6,433,119 | 06/30/2026 Filed 2026-08-13 | SCHEDULE 13G/AAmendment 9 | Open filing 0000908834-26-000405 Dispute this row |
| Kim, David T. Common Stock, par value $0.00001 per share (the "Shares") | 9.99 | 6,433,119 | 06/30/2026 Filed 2026-08-13 | SCHEDULE 13G/AAmendment 9 | Open filing 0000908834-26-000405 Dispute this row |
| Linn, Michael G. Common Stock, par value $0.00001 per share (the "Shares") | 9.99 | 6,433,119 | 06/30/2026 Filed 2026-08-13 | SCHEDULE 13G/AAmendment 9 | Open filing 0000908834-26-000405 Dispute this row |
| Luo Patrick (Cheng) Common Stock, par value $0.00001 per share (the "Shares") | 9.99 | 6,433,119 | 06/30/2026 Filed 2026-08-13 | SCHEDULE 13G/AAmendment 9 | Open filing 0000908834-26-000405 Dispute this row |
| Roberts, Jr., Thomas G. Common Stock, par value $0.00001 per share (the "Shares") | 9.99 | 6,433,119 | 06/30/2026 Filed 2026-08-13 | SCHEDULE 13G/AAmendment 9 | Open filing 0000908834-26-000405 Dispute this row |
| Saito Edric C. Common Stock, par value $0.00001 per share (the "Shares") | 9.99 | 6,433,119 | 06/30/2026 Filed 2026-08-13 | SCHEDULE 13G/AAmendment 9 | Open filing 0000908834-26-000405 Dispute this row |
| Short Daniel S. Common Stock, par value $0.00001 per share (the "Shares") | 9.99 | 6,433,119 | 06/30/2026 Filed 2026-08-13 | SCHEDULE 13G/AAmendment 9 | Open filing 0000908834-26-000405 Dispute this row |
| Spokes, Andrew J. M. Common Stock, par value $0.00001 per share (the "Shares") | 9.99 | 6,433,119 | 06/30/2026 Filed 2026-08-13 | SCHEDULE 13G/AAmendment 9 | Open filing 0000908834-26-000405 Dispute this row |
| Warren, John R. Common Stock, par value $0.00001 per share (the "Shares") | 9.99 | 6,433,119 | 06/30/2026 Filed 2026-08-13 | SCHEDULE 13G/AAmendment 9 | Open filing 0000908834-26-000405 Dispute this row |
| Wehrly, Mark C. Common Stock, par value $0.00001 per share (the "Shares") | 9.99 | 6,433,119 | 06/30/2026 Filed 2026-08-13 | SCHEDULE 13G/AAmendment 9 | Open filing 0000908834-26-000405 Dispute this row |
| STATE STREET CORPORATION COMMON STOCK | 5.2 | 3,321,554.00 | 06/30/2026 Filed 2026-08-07 | SCHEDULE 13G | Open filing 0000093751-26-000527 Dispute this row |
| STATE STREET CORPORATION COMMON STOCK | 4.9 | 3,116,804.00 | 03/31/2026 Filed 2026-05-12 | SCHEDULE 13G | Open filing 0000093751-26-000283 Dispute this row |
| Vanguard Capital Management Common Stock | 5.09 | 3,250,003 | 03/31/2026 Filed 2026-04-30 | SCHEDULE 13G | Open filing 0002100119-26-000884 Dispute this row |
| Vanguard Portfolio Management Common Stock | 5.53 | 3,533,015 | 03/31/2026 Filed 2026-04-29 | SCHEDULE 13G | Open filing 0002100121-26-000589 Dispute this row |
| The Vanguard Group Common Stock | 0 | 0 | 03/13/2026 Filed 2026-03-27 | SCHEDULE 13G/AAmendment 5 | Open filing 0000102909-26-002110 Dispute this row |
| RTW Investments, LP Common Stock, $0.00001 par value | 8.1 | 5,059,053.00 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 6 | Open filing 0001493215-26-000042 Dispute this row |
| Roderick Wong Common Stock, $0.00001 par value | 8.1 | 5,059,053.00 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 6 | Open filing 0001493215-26-000042 Dispute this row |
| Wellington Management Group LLP Common Stock | 5.1 | 3,171,423.00 | 12/31/2025 Filed 2026-02-10 | SCHEDULE 13G | Open filing 0000902219-26-000033 Dispute this row |
| Wellington Group Holdings LLP Common Stock | 5.1 | 3,171,423.00 | 12/31/2025 Filed 2026-02-10 | SCHEDULE 13G | Open filing 0000902219-26-000033 Dispute this row |
| Wellington Investment Advisors Holdings LLP Common Stock | 5.1 | 3,171,423.00 | 12/31/2025 Filed 2026-02-10 | SCHEDULE 13G | Open filing 0000902219-26-000033 Dispute this row |
| Farallon Capital Partners, L.P. Common Stock, par value $0.00001 per share (the "Shares") | 0.5 | 283,062 | 12/31/2025 Filed 2026-02-06 | SCHEDULE 13G/AAmendment 8 | Open filing 0000908834-26-000054 Dispute this row |
| Farallon Capital Institutional Partners, L.P. Common Stock, par value $0.00001 per share (the "Shares") | 0.5 | 290,850 | 12/31/2025 Filed 2026-02-06 | SCHEDULE 13G/AAmendment 8 | Open filing 0000908834-26-000054 Dispute this row |
| Farallon Capital Institutional Partners II, L.P. Common Stock, par value $0.00001 per share (the "Shares") | 0.1 | 91,421 | 12/31/2025 Filed 2026-02-06 | SCHEDULE 13G/AAmendment 8 | Open filing 0000908834-26-000054 Dispute this row |
| Farallon Capital Institutional Partners III, L.P. Common Stock, par value $0.00001 per share (the "Shares") | 0.1 | 39,417 | 12/31/2025 Filed 2026-02-06 | SCHEDULE 13G/AAmendment 8 | Open filing 0000908834-26-000054 Dispute this row |
| Four Crossings Institutional Partners V, L.P. Common Stock, par value $0.00001 per share (the "Shares") | 0.1 | 53,343 | 12/31/2025 Filed 2026-02-06 | SCHEDULE 13G/AAmendment 8 | Open filing 0000908834-26-000054 Dispute this row |
| Farallon Capital Offshore Investors II, L.P. Common Stock, par value $0.00001 per share (the "Shares") | 0.9 | 565,080 | 12/31/2025 Filed 2026-02-06 | SCHEDULE 13G/AAmendment 8 | Open filing 0000908834-26-000054 Dispute this row |
| Farallon Capital (AM) Investors, L.P. Common Stock, par value $0.00001 per share (the "Shares") | 0.1 | 36,181 | 12/31/2025 Filed 2026-02-06 | SCHEDULE 13G/AAmendment 8 | Open filing 0000908834-26-000054 Dispute this row |
| Farallon Capital F5 Master I, L.P. Common Stock, par value $0.00001 per share (the "Shares") | 0.2 | 121,094 | 12/31/2025 Filed 2026-02-06 | SCHEDULE 13G/AAmendment 8 | Open filing 0000908834-26-000054 Dispute this row |
| Farallon Healthcare Partners Master, L.P. Common Stock, par value $0.00001 per share (the "Shares") | 7.6 | 4,767,564 | 12/31/2025 Filed 2026-02-06 | SCHEDULE 13G/AAmendment 8 | Open filing 0000908834-26-000054 Dispute this row |
| Farallon Partners, L.L.C. Common Stock, par value $0.00001 per share (the "Shares") | 9.8 | 6,126,919 | 12/31/2025 Filed 2026-02-06 | SCHEDULE 13G/AAmendment 8 | Open filing 0000908834-26-000054 Dispute this row |
Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.
What was read
2,715,586 filings read, dated 2004-06-14 to 2026-11-20: Forms 3, 3/A, 4, 4/A, 5, 5/A.
Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.
| Filing year | Filings read |
|---|---|
| 2015 | 131,968 |
| 2016 | 222,642 |
| 2017 | 222,009 |
| 2018 | 223,345 |
| 2019 | 216,482 |
| 2020 | 226,343 |
| 2021 | 249,835 |
| 2022 | 231,682 |
| 2023 | 229,674 |
| 2024 | 234,045 |
| 2025 | 235,520 |
| 2026 | 263,828 |
Filings made before the SEC required XML are listed, not extracted.